Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
16/05/2025
Forte Biosciences (FBRX.US): The Q1 financial report for 2025 achieved revenue of 0 US dollars, the same as the previous value; earnings per share was -1.37 US dollars, compared to the previous value of -4.03 US dollars.
Latest
2 m ago
Hong Kong stocks surge | Geely Auto (00175.HK) rose nearly 3% in early trading, with first-quarter net profit soaring 2.6 times year-on-year, driven by strong growth in new energy business.
2 m ago
Nanshan Zhishang: Work has been carried out with a number of domestic robot manufacturing companies on the delivery of product samples and other related tasks.
4 m ago
The chemical pharmaceutical sector fluctuated and rose, with Hengdi Pharmaceutical rising more than 10%, Xinhua Pharmaceutical hitting the limit up, Jinshiya Pharmaceutical, Haichuang Pharmaceutical, and Doris Medical following the trend.
5 m ago
Hang Seng Index fell more than 1%, Hang Seng Technology Index dropped 0.84%; NetEase surged against the market, up 15%.
6 m ago
Hong Kong stocks surge | OneSunshine (02522.HK) rose more than 5% in intraday trading, planning to repurchase shares with up to 100 million Hong Kong dollars. The company is digging deep into the value of medical imaging data.
See all latest